Can a cancer biopsy predict who responds to a new immunotherapy?
Disease control
Not yet recruiting
This phase 2 trial is testing the drug glofitamab in people with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL). Glofitamab is a type of immunotherapy that helps the body's T-cells attack cancer cells. The study uses tumor biopsies tak…
Phase: PHASE2 • Sponsor: Joshua Brody • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC